Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.
about
NetFCM: a semi-automated web-based method for flow cytometry data analysis.Functional avidity and IL-2/perforin production is linked to the emergence of mutations within HLA-B*5701-restricted epitopes and HIV-1 disease progressionT-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infectionBaseline CD4+ T cell counts correlates with HIV-1 synonymous rate in HLA-B*5701 subjects with different risk of disease progression.Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV InfectionTargeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles.The intra-host evolutionary and population dynamics of human immunodeficiency virus type 1: a phylogenetic perspective.HIV and HLA class I: an evolving relationshipAccumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype.
P2860
Q30837588-7F4DC3A8-91D6-427C-B201-FFB3297CE8F2Q33712891-F17436EC-71EF-42EB-B2D4-AA3C9DA6B0C1Q33916550-B9CAC426-1692-45F0-B9FF-F48E37E64254Q35238084-EF967B7B-FA7F-42D8-82F1-16A7965F3BD5Q35786633-FCD45F49-8095-47DB-9EA5-96A0D1D73B29Q36634956-A4B823C0-79E8-4741-B83A-A5FCB40F8CE9Q37123118-44619BC8-CFD4-4CEB-BF91-48DBE293E274Q37481983-4D3F37BB-370B-49E1-98FD-3AF971AC53AFQ38045636-90E0ED2D-FF59-47CF-B13E-DA137BC9BE52Q40428899-5104F333-0741-4CB4-BDD0-0D74F9C6F726Q42130441-C37E3CEC-37D1-46EF-AF33-3C3376466A65Q47626019-5A52EA49-0F11-4D6E-88D6-AB0CE0760687
P2860
Combination of immune and viral factors distinguishes low-risk versus high-risk HIV-1 disease progression in HLA-B*5701 subjects.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combination of immune and vira ...... ession in HLA-B*5701 subjects.
@en
type
label
Combination of immune and vira ...... ession in HLA-B*5701 subjects.
@en
prefLabel
Combination of immune and vira ...... ession in HLA-B*5701 subjects.
@en
P2093
P2860
P50
P356
P1433
P1476
Combination of immune and vira ...... ession in HLA-B*5701 subjects.
@en
P2093
Annika C Karlsson
Marco Salemi
Mark A Wallet
Mattia C Prosperi
Melissa M Norström
Wendy Hartogensis
P2860
P304
P356
10.1128/JVI.01165-12
P407
P577
2012-07-03T00:00:00Z